What is the global market size of Digital Pathology Market?

Digital Pathology Market size was valued at USD 975.50 million in 2021 and is poised to grow from USD 1051.59 million in 2022 to USD 1917.77 million by 2030, at a CAGR of 7.8% during the forecast period (2023-2030).

Who are the key vendors in the Global Digital Pathology Market?

The Global Digital Pathology Market is highly competitive, with a large number of players operating in the space. Some of the key players in the market are focused on product development and innovation, strategic partnerships and collaborations, and mergers and acquisitions to strengthen their market position. They are also investing heavily in research and development activities to develop advanced digital pathology solutions that offer improved accuracy, speed, and efficiency. In addition, companies are expanding their geographic reach by targeting emerging markets in Asia-Pacific and Latin America, which offer significant growth opportunities due to increasing healthcare expenditure and the rising prevalence of chronic diseases. Overall, the competitive landscape of the digital pathology market is expected to remain intense, with companies vying for a larger share of the rapidly growing market. 'Philips Healthcare (Netherlands)', 'Leica Biosystems (Germany)', 'Roche Diagnostics (Switzerland)', 'Hamamatsu Photonics (Japan)', '3DHISTECH (Hungary)', 'Ventana Medical Systems (US)', 'GE Healthcare (US)', 'Apollo Enterprise Imaging (US)', 'Olympus Corporation (Japan)', 'Mikroscan Technologies (US)', 'Inspirata (US)', 'PerkinElmer (US)', 'Huron Digital Pathology (Canada)', 'Sectra AB (Sweden)', 'PathAI (US)', 'Indica Labs (US)', 'F. Hoffmann-La Roche (Switzerland)', 'Nikon Corporation (Japan)', 'Danaher Corporation (US)', 'Visiopharm (Denmark)'.

What is the key driver of Global Digital Pathology Market?

Continuous advancements in digital imaging technology, such as whole-slide imaging (WSI), high-resolution scanners, and image analysis software, are driving the adoption of digital pathology. These technological innovations offer improved image quality, faster scanning times, and enhanced analysis capabilities, leading to more accurate and efficient diagnoses. For example, the development of deep learning algorithms and artificial intelligence (AI) tools has enabled automated image analysis and detection of abnormalities in pathology slides, aiding pathologists in their decision-making process.

What is the key market trend for Global Digital Pathology Market?

Telepathology and Remote Consultation: The increasing adoption of telepathology allows for remote diagnosis and consultation, enabling pathologists to collaborate and provide expert opinions regardless of geographical constraints. Telepathology has gained prominence during the COVID-19 pandemic, as it facilitates remote working and minimizes the risk of exposure for pathologists. For example, pathologists can remotely review and discuss cases with colleagues, participate in multidisciplinary tumor boards, or provide consultations to underserved areas or regions facing a shortage of pathology expertise.

Which region accounted for the largest share in Global Digital Pathology Market?

In 2022, North America dominated the global digital pathology market. This can be attributed to various factors, including increasing government initiatives towards the development of technologically advanced pathologies, continual investments in research and development, rising adoption of digital imaging, and the presence of key market players in the region. For instance, PathAI launched AISight, a digital pathology platform in 13 leading health systems across the U.S. to participate in an Early Access Program. The increasing usage of digital pathology in academic research and disease diagnosis is also contributing to the growth of the regional market.

Digital Pathology Market Size, Share, Growth Analysis, By Product(Software {Type [Integrated and Standalone (Information Management System and Image Analysis Software)], By Deployment Mode (On Premises and Cloud Based)}, Scanners (Brightfield Scanners and Other Scanners), Device), By Application(Drug discovery & development, academic research, and disease diagnosis), By Type(Human pathology, Veterinary pathology), By End user(Pharmaceutical and biotechnology, Hospitals & Reference Laboratories, Academic & Research Institutes), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35G2172 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 115 | Figures: 77

Digital Pathology Market News

In August 2024, the next-generation digital pathology platform from Philips Healthcare was recently launched, the Philips IntelliSite Pathology Solution 3.0. The upgrade improves image quality and integrates artificial intelligence algorithms to support diagnosis with greater accuracy. The new platform seeks to enhance global pathologist workflow efficiency and diagnostic precision.
In July 2024, Leica Biosystems is releasing its new product, Aperio GT 450 Scanner. Its unique selling point is that it has better speed and resolution as compared to other such scanners present in the market. The ultra-modern scanner can scan many slides in a very short time and has improved image clarity. It has been meant for simplifying the pathology processes and facilitate the performance of advanced diagnoses.
In June 2024, In June 2024 Nikon Instruments launched DPA-NIS a new digital pathology imaging system. The system provides high resolution images and has seamless integration with AI based diagnostic tools. By enabling accurate and high-quality digital images for analysis, it is set to improve pathology research and clinical diagnostics.

Digital Pathology Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Digital Pathology Market size was valued at USD 1051.59 million in 2022 and is poised to grow from USD 1133.61 million in 2023 to USD 2067.36 million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The fluctuating context of the global digital pathology market brings competition among its major players, inspiring innovation and progress. At the forefront of this sector are international giants like Philips Healthcare, Leica Biosystems, and Nikon Instruments who provide cutting-edge digital imaging and analytical tools. These firms focus on enhancing diagnostic accuracy, integrating AI, and expanding their technological offerings. The competition fosters rapid advancements and diverse solutions, catering to the increasing demand for efficient and precise pathology diagnostics worldwide. 'Philips Healthcare (Netherlands) ', 'Roche Diagnostics (Switzerland) ', 'Hamamatsu Photonics (Japan) ', '3DHISTECH (Hungary) ', 'GE Healthcare (US) ', 'Apollo Enterprise Imaging (US) ', 'Olympus Corporation (Japan) ', 'Mikroscan Technologies (US) ', 'Inspirata (US) ', 'PerkinElmer (US) ', 'Huron Digital Pathology (Canada) ', 'Sectra AB (Sweden) ', 'PathAI (US) ', 'Indica Labs (US) ', 'F. Hoffmann-La Roche (Switzerland) ', 'Nikon Corporation (Japan) ', 'Danaher Corporation (US) ', 'Visiopharm (Denmark) ', 'Densitas (Canada) ', 'Objective Pathology (US) ', 'QPath (US)'

Technological innovations such as whole-slide imaging (WSI), image analysis tools, and artificial intelligence (AI) have completely transformed digital pathology. As a result of these progressions, digital pathology is increasingly favored by healthcare providers on account of improved diagnosis accuracy, operational efficiency and automated workflow processes.

Rise of Fully Cloud-Based Digital Pathology for Scalable, Collaborative, and Personalized Healthcare: The global digital pathology market has experienced tremendous growth owing to recent progressions in technology alongside increasing demands for eco-friendly diagnostic possibilities. Digital photography can be used for the collection, management, and analysis of pathological data. The widespread use of Whole Slide Imaging (WSI), which enables pathologists to view entire tissue slides digitally, is an impressive trend.

Due to its highly developed healthcare systems, sophisticated technology uptake and substantial investment in research and development, North America is the global leader in digital pathology. The region has an abundance of top-notch tech firms and an ecosystem which encourages growths in digital pathology innovations. Also, the North American healthcare services are directed towards enhancing accuracy in diagnosis as well as efficiency; thus, fueling the need for these digital solutions. Government support for healthcare IT advancements, coupled with the growing prevalence of chronic diseases, further fuels digital pathology market growth, positioning North America as a leader in the digital pathology sector.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Digital Pathology Market News

Digital Pathology Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Digital Pathology Market?

Who are the key vendors in the Digital Pathology Market?

What is the key driver of Digital Pathology Market?

What is the key market trend for Digital Pathology Market?

Which region accounted for the largest share in Digital Pathology Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300